Our study affirms that TNFRSF10A, SORT1 and CTSL1 are significantly elevated not only in early RA but also in established disease, suggesting their potential as candidate biomarkers for the disease. This evidence concerns the gene TNFRSF10A and rheumatoid arthritis.